Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Organon & Co. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 727 | 11 | 726 | +10 |
| Shares | 198.5M | 33.9M | 199.3M | +34.7M (+21.1%) |
| Value | $4.11B | $700.7M | $3.81B | +$401.6M (+11.8%) |
11 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (91)
Institutions that held Organon & Co. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (81)
Institutions that held Organon & Co. at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (11)
Institutions that held Organon & Co. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 32,579,067 | $674.4M |
| Greylin Investment Mangement Inc | 809,119 | $16.7M |
| Susquehanna Fundamental Investments, LLC | 429,370 | $8.89M |
| Karpas Strategies, LLC | 14,412 | $298.3K |
| Buckingham Strategic Wealth, LLC | 9,740 | $201.6K |
| Benjamin F. Edwards & Company, Inc. | 8,258 | $171.0K |
| JJJ Advisors Inc. | 133 | $2.75K |
| Institutional & Family Asset Management, LLC | 81 | $1.68K |
| Private Ocean, LLC | 45 | $927 |
| Emfo, LLC | 32 | $663 |
| Sofos Investments, Inc. | 12 | $248 |